Gene Therapy: Can CDMOs Solve the Manufacturing Bottleneck?
The gene therapy market is booming. Viral vectors, the key delivery systems for gene therapies,…
The gene therapy market is booming. Viral vectors, the key delivery systems for gene therapies,…
The rise of adenoviral Covid-19 vaccines highlights the potential of companies using similar technology in…
Since the debut of Imlygic in 2015, no other oncolytic virus cancer therapies have been…
Taking advantage of the ability of viruses to manipulate life is opening new doors for…
Valo Therapeutics is operating both in the UK and Finland to develop a cancer vaccine…
French biotech Transgene has ceased the development of a therapeutic cancer vaccine that failed to…
Abalos Therapeutics launches today with €12M in Series A funding to get the development of…
A phase III trial testing an oncolytic virus treatment for liver cancer, developed by the…
Boehringer Ingelheim is paying €210M to acquire all the remaining shares of ViraTherapeutics, an Austrian…
In an early study at Queen Mary University in London, a modified flu virus has…
Serial entrepreneur John Beadle is now at the helm of PsiOxus, an Oxford biotech with…
We talked to CEO Øystein Soug and CMO Magnus Jäderberg of Targovax about why the…